Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SSX3 Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)

SSX3 Origine: Humain Hôte: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
N° du produit ABIN2733103
  • Antigène Voir toutes SSX3 Protéines
    SSX3 (Synovial Sarcoma, X Breakpoint 3 (SSX3))
    Type de proteíne
    Recombinant
    Attributs du protein
    Transcript Variant 2
    Origine
    Humain
    Source
    • 2
    • 1
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette SSX3 protéine est marqué à la Myc-DYKDDDDK Tag.
    Application
    Antibody Production (AbP), Standard (STD)
    Attributs du produit
    • Recombinant human Synovial sarcoma, X breakpoint 3 (SSX3), transcript variant 2 (transcript variant 2) protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
    Pureté
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
    Top Product
    Discover our top product SSX3 Protéine
  • Indications d'application
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Commentaires

    The tag is located at the C-terminal.

    Restrictions
    For Research Use only
  • Concentration
    50 μg/mL
    Buffer
    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
    Stock
    -80 °C
    Stockage commentaire
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Antigène
    SSX3 (Synovial Sarcoma, X Breakpoint 3 (SSX3))
    Abstract
    SSX3 Produits
    Synonymes
    CT5.3 Protein, SSX2 Protein, SSX3 Protein, SSX family member 3 Protein, protein SSX2 Protein, SSX3 Protein, LOC741661 Protein
    Sujet
    The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. While some of the related SSX genes are involved in t(X18)(p11.2q11.2) translocations that are characteristically found in all synovial sarcomas, this gene does not appear to be involved in such translocations.
    Poids moléculaire
    19.3 kDa
    NCBI Accession
    NP_783642
Vous êtes ici:
Support technique